Gastroenterology News

As their parents age, many of our physician clients have asked us about long-term care insurance.

AI has already made its mark in gastroenterology as a tool for detecting gastrointestinal lesions, adenomas and inflammatory bowel disease. However, its next phase of evolution might seem the most unlikely: Aiding colonoscopy preparation.

CMS has released its proposed 2025 Medicare Physician Fee Schedule, or PFS, which includes a 2.93% cut in physician payments from the previous year, according to a press release.

The FDA has granted orphan drug designation to PharmassêtX’s PSX-514, a drug derived from an active component of green tea, for the treatment of pouchitis, according to a company press release.

About 40% of cancer cases and nearly half of cancer deaths among U.S. adults aged 30 years or older can be attributable to modifiable risk factors, according to a study led by American Cancer Society researchers.

A 2023 outbreak of Shiga toxin-producing Escherichia coli O157:H7 involving at least 13 children in Utah was linked to untreated municipal irrigation water, according to a CDC investigation published in Morbidity and Mortality Weekly Report.

Although adherence to standardized reporting guidelines ranged from 82.4% to 92.2% in published trials of colorectal cancer screening, researchers found that reporting of trial registration and informed consent materials could be improved.

A continuous risk score accurately predicted waitlist dropout and post-liver transplantation outcomes in patients with hepatocellular carcinoma, even over the course of several UNOS policy changes, researchers reported.

Bloomberg Philanthropies announced that it has donated $1 billion to make Johns Hopkins University’s medical school free for most of its students seeking an MD.

In a Healio exclusive, Andres J. Acosta, MD, PhD, highlights data demonstrating that the MyPhenome test may serve as a biomarker to determine whether a patient with obesity will be a “good responder” to semaglutide.